オーダーメイド医療動向

Abstract

In This Issue...

In vitro diagnostics (IVD) and molecular diagnostics are multibillion-dollar industries. Together, they play critical roles in the trend toward personalized medicine. Pharmaceutical and biotechnology companies are turning to personalized medicine to help improve the drug development process and speed the approval of new drugs. In this report, we discuss the role of IVD and molecular diagnostics in personalized medicine, profile companies in the field, discuss key trends and issues, and ponder the future of personalized medicine.

Table of Contents

Introduction

The Role of IVD in Personalized Medicine

• Targeted Cancer Therapies
• Drug-Metabolizing Enzymes
• HIV-Resistance Testing

Diagnostic Companies in Personalized Medicine

• Virco Lab
• Monogram Biosciences
• DakoCytomation
• Vysis
• Genzyme Genetics
• Roche Diagnostics
• Affymetrix
• Third Wave Technologies

Key IVD Trends in Personalized Medicine

• Combination Drug/Diagnostic Products
• Increasing Use of Pharmacogenetic Tests
• Multiplex Testing

Outlook

• Successful Business Models Cost
• Patients' Acceptance of Personalized Medicine